Investors are Shenzhen Venture Capital and Gaotejia Investment

It is reported that the smart medical overall solution provider “Lianxin” announced the completion of 150 million yuan in the B + round of financing.

Prior to this, Lianxin completed a 200 million yuan B round of financing in August 2018, led by Gaotejia Investment, followed by Yuanxing Capital. A round of financing was completed in 2017, and the investor was CICC.

Lianxin is a smart medical overall solution provider. The product entry point is “smart ward”. Lianxin launched the “Medical Interoperability” platform, relying on ICT and Internet technologies, to provide hospitals, doctors and nurses with corresponding smart medical solutions.

Specifically, the products include medical-grade intelligent hardware, application software, system platforms, in-hospital Internet of Things, and big data medical clouds, covering smart ward interactive platforms, early evaluation of conditions, clinical medical education, intelligent nursing, and fully closed-loop infusion management , Mobile medical / nursing workstation, intelligent device management, intelligent collection of vital signs, intelligent medicine cabinet, perioperative closed-loop management, Bluetooth IoT in the hospital and other fields.

Providing smart medical services,

Image from Lianxin official website

“Smart hospitals” is a major trend in the development of medical institutions. Recently, this policy has been frequently mentioned by the National Health and Family Planning Commission, which has activated the always quiet medical Internet of Things market. In particular, the “National Standards and Standards for Hospital Informatization Construction (Trial)” formulated in April 2018, policy dividends have brought significant benefits to the industry.

Profitability is the key to assessing the track. Recently, relevant policy documents were issued, and the hospital’s repayment cycle to suppliers was shortened to three months, which improved the charging method and raised the ceiling.

At present, Lianxin products have been applied in more than 700 hospitals across the country, including Peking Union Medical College Hospital, Peking University First Hospital, Zhengzhou University First Affiliated Hospital, Shanghai Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Fushan University Affiliated Huashan Hospital, Xiangya Hospital of Central South University, Nanfang Hospital of Southern Medical University, First Affiliated Hospital of Zhejiang University School of Medicine and many other top three hospitals.

This track is not an emerging industry. Many of the leading companies have a business history of 20-30 years, and many of them have already been listed. The advancement of science and technology and the encouragement of policies have brought new opportunities to this “old” industry. The top companies in the industry are Lianxin, Anke, Honeywell, Lianzhong Wisdom, Medical Technology, etc.